A Phase 1, 2-Part, Multicenter, First-In-Human Dose-Escalation and Dose-Expansion Study of DS-1103a Combination Therapy in Subjects With Advanced Solid Tumors
OPEN TO ACCRUAL
I
NCT05765851
sgraff1@BrownHealth.org